Antidiabetic activity of gossypin, a pentahydroxyflavone glucoside, in streptozotocin-induced experimental diabetes in rats

Journal of Diabetes

Volumn 4, Issue 1, 2012, Pages 41-46

  Venkatesan, Thamizhiniyan ^a   Sorimuthu Pillai, Subramanian ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Antidiabetic; Diabetes; Gossypin; Streptozotocin

Indexed keywords

GLICLAZIDE; GLUCOSE; GOSSYPINE; HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLYCOGEN ANALYSIS; HEMOGLOBIN BLOOD LEVEL; INSULIN BLOOD LEVEL; LIVER; MUSCLE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; STREPTOZOCIN DIABETES; UREA BLOOD LEVEL;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FLAVONOIDS; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; MALE; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 84857434220     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2011.00145.x     Document Type: Article

References (30)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33 (Suppl.): S62-9.
2. Krentz AJ, Bailey CJ. Oral antidiabetic agents: Current role in type 2 diabetes mellitus. Drugs. 2005; 65: 385-411.
3. Winkel BSJ. The biosynthesis of flavonoids. In: Grotewold E (ed.). The Science of Flavonoids. Springer, New York, NY, 2006; 71-95.
4. Hollman PC, Bijsman MN, van Gameren Y, Cnossen EP, de Vries JH, Katan MB. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res. 1999; 3: 569-73.
5. Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol Ther. 2002; 96: 67-202.
6. Heim KE, Tagliaferro AR, Bobilya DJ. Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships. J Nutr Biochem. 2002; 13: 572-84.
7. Gautam P, Flora SJ. Oral supplementation of gossypin during lead exposure protects alteration in heme synthesis pathway and brain oxidative stress in rats. Nutrition. 2010; 26: 563-70.
8. Lu N, Li Y, Qin H, Zhang YL, Sun CH. Gossypin up-regulates LDL receptor through activation of ERK pathway: A signaling mechanism for the hypocholesterolemic effect. J Agric Food Chem. 2008; 56: 11526-32.
9. Vijayaraghavan R, Gautam A, Sharma M, Satish HT, Pant SC, Ganesan K. Comparative evaluation of some flavonoids and tocopherol acetate against the systemic toxicity induced by sulphur mustard. Indian J Pharmacol. 2008; 40: 114-20.
10. Kunnumakkara AB, Nair AS, Ahn KS et al. Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-kappaB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation ofosteoclastogenesis. Blood. 2007; 109: 5112-21.
11. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: An overview. Indian J Med Res. 2007; 125: 451-72.
12. Rakieten N, Rakieten ML, Nadkarni MV. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep. 1963; 29: 91-8.
13. Morales MA, Jabbagy AJ, Terenizi HR. Mutations affecting accumulation of glycogen. Neurospora Newsl. 1973; 20: 24-5.
14. Sasaki T, Matsy S, Sonae A. Effect of acetic acid concentration on the colour reaction in the O-toluidine boric acid method for blood glucose estimation. RinshKagaku. 1972; 1: 346-53 (in Japanese).
15. Drabkin DL, Austin JH. Spectrophotometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J Biol Chem. 1932; 98: 719-33.
16. Nayak SS, Pattabiraman TN. A new colorimetric method for the estimation of glycosylated hemoglobin. Clin Chim Acta. 1981; 109: 267-74.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193: 265-75.
18. Natelson S, Scott ML, Beffa C. A rapid method for the estimation of urea in biologic fluids. Am J Clin Pathol. 1951; 21: 275-81.
19. Tjälve H, Wilander E, Johansson EB. Distribution of labelled streptozotocin in mice: uptake and retention in pancreatic islets. J Endocrinol. 1976; 69: 455-6.
20. Ar'Rajab A, Ahrén B. Long-term diabetogenic effect of streptozotocin in rats. Pancreas. 1993; 8: 50-7.
21. Ganda OP, Rossini AA, Like AA. Studies on streptozotocin diabetes. Diabetes. 1976; 25: 595-603.
22. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15: 539-53.
23. Mann CJ, Ayuso E, Anguela XM, Bosch F. Skeletal muscle metabolism in the pathology and treatment of type 1 diabetes. Curr Pharm Des. 2010; 16: 1002-20.
24. Kajimoto Y, Kaneto H. Role of oxidative stress in pancreatic beta-cell dysfunction. Ann N Y Acad Sci. 2004; 1011: 168-76.
25. Coskun O, Kanter M, Korkmaz A, Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res. 2005; 51: 117-23.
26. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med. 2004; 19: 1175-80.
27. Nathan DM, Turgeon H, Regan S. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia. 2007; 50: 2239-44.
28. Thorburn AW, Gumbiner B, Bulacan F, Wallace P, Henry RR. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest. 1990; 85: 522-9.
29. Freyse EJ, Rebrin K, Schneider T, Petrzika M, Fischer U. Increased urea synthesis in insulin-dependent diabetic dogs maintained normoglycemic: Effect of portal insulin administration and food protein content. Diabetes. 1996; 45: 667-74.
30. Green M, Miller LL. Protein catabolism and protein synthesis in perfused livers of normal and alloxan-diabetic rats. J Biol Chem. 1960; 235: 3202-8.